SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The turnover zoomed to Rs. 740.25 millions, up 56.72% for the December 2024 quarter as against Rs. 472.34 millions during the year-ago period.The company almost doubled its revenue to Rs. 319.90 millions  from Rs. 39.63 millions in the quarter ended December 2024.OP of the company witnessed a marginal growth to 181.56 millions from 59.17 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 740.25 472.34 56.72 2101.56 1652.16 27.20 2087.02 2367.14 -11.83
Other Income 23.22 25.21 -7.89 54.20 67.92 -20.20 92.79 57.34 61.82
PBIDT 181.56 59.17 206.84 477.77 271.90 75.72 323.46 398.85 -18.90
Interest 2.55 2.26 12.83 6.99 5.97 17.09 8.14 4.13 97.09
PBDT 410.85 56.91 621.93 669.77 265.93 151.86 315.32 360.13 -12.44
Depreciation 24.13 4.12 485.68 58.26 12.60 362.38 16.63 12.05 38.01
PBT 386.72 52.79 632.56 611.51 253.33 141.39 298.69 348.08 -14.19
TAX 66.82 13.16 407.75 123.73 64.19 92.76 74.06 80.87 -8.42
Deferred Tax -13.80 -0.56 2364.29 0.40 -1.37 -129.20 -1.54 4.55 -133.85
PAT 319.90 39.63 707.22 487.78 189.14 157.89 224.63 267.21 -15.94
Equity 132.29 131.44 0.65 132.42 131.44 0.75 132.19 130.99 0.92
PBIDTM(%) 24.53 12.53 95.79 22.73 16.46 38.14 15.50 16.85 -8.02

Jagsonpal Pharma Share Price

212.25 1.95 (0.93%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.10
Dr. Reddys Lab 1287.95
Cipla 1334.85
Zydus Lifesciences 901.65
Lupin 2350.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×